Franco Gaboardi

Dr. Franco Gaboardi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2018 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
FGFranco Gaboardi
Franco Gaboardi
GPGiovannalberto Pini
Giovannalberto Pini
NSNazareno Suardi
Nazareno Suardi
FMFrancesco Montorsi
Francesco Montorsi
GPGiovanni Passaretti
Giovanni Passaretti
SSSalvatore Smelzo
Salvatore Smelzo

1 October 2021 in Journal of Endourology
Verified
Journal Article
Closed access
UIUmar Iqbal
Umar Iqbal
AEAhmed S. Elsayed
Ahmed S. Elsayed
ZJZhe Jing
Zhe Jing
MSMichael Stoeckle
Michael Stoeckle
CWCarl Wijburg
Carl Wijburg
KGKhurshid Ahad Guru
Khurshid Ahad Guru
Introduction: We sought to describe the incidence, risk factors, and survival outcomes associated with pathological upstaging from non-muscle invasive bladder cancer (NMIBC) to muscle invasive bladder cancer (MIBC) after robot-assisted radical cystectomy (RARC). Methods: We reviewed the International Robotic Cystectomy Consortium database between 2004 and 2020. Upstaging was defined as ≥pT2 or pN+ at final pathology from clinical <T2N0M0. Descriptive statistics were used to summarize data. Cochran-Armitage test was used to depict upstaging trend over time. Multivariate regression models were used to depict variables associated with upstaging. Kaplan Meier curves were used to describe disease-specific (DSS), recurrence-free (RFS), and overall survival (OS). Results: 463 patients underwent RARC for NMIBC. Upstaging occurred in 145 (31%) patients. Upstaged patients were older (70 vs 67 years, p <0.01), more likely to have American Society of Anesthesiologists score (≥3) (55% vs 44%, p=0.04) and had higher rate of preoperative hydronephrosis (26% vs 10%, p <0.01). They were more likely to have positive surgical margins (10% vs 3%, p= 0.01), recurrences (28% vs 9%, p<0.01), and to receive adjuvant/salvage treatment (26% vs none, p <0.01). On multivariate analysis, upstaging was associated with older age (OR 1.04; CI 1.01-1.07, p<0.01), cT1 vs cTis (OR 4.25; CI 1.57-11.48, p <0.01), cT1 vs cTa (OR 2.92; CI 1.40-6.06, p<0.01), and preoperative hydronephrosis (OR 3.18; CI 1.60-6.32, p<0.01). Upstaged patients had worse 5-year RFS (53 % vs 85%, log rank p<0.01), DSS (66% vs 93%, log rank p<0.01), and OS (49% vs 74%, log rank p<0.01). The rate of upstaging did not significantly change over time (38% in 2004 to 27% in 2019, p=0.17). Conclusion: Upstaging to MIBC occurred in a significant proportion of patients after RARC for NMIBC and was associated with worse survival outcomes. Older patients, those with cT1 disease and hydronephrosis were more likely to upstage.

1 December 2016 in Minerva Urology and Nephrology
Verified
Journal Article
Closed access
GPGiovannalberto Pini
Giovannalberto Pini
SMSusan Matin
Susan Matin
NSNazareno Suardi
Nazareno Suardi
MDMihir Desai
Mihir Desai
IGInderbir Gill
Inderbir Gill
FPFrancesco Porpiglia
Francesco Porpiglia
Article: Robot assisted lymphadenectomy in urology: pelvic, retroperitoneal and inguinal - Minerva Urologica e Nefrologica 2017 February;69(1):38-55 - Minerva Medica - Journals

1 November 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Guglielmo ManticaGuglielmo Mantica
Guglielmo Mantica
NSNazareno Suardi
Nazareno Suardi
SSSalvatore Smelzo
Salvatore Smelzo
Francesco EspertoFrancesco Esperto
Francesco Esperto
Francesco ChierigoFrancesco Chierigo
Francesco Chierigo
GCGianpiero Cardone
Gianpiero Cardone
Aim: To assess urologists’ proficiency in the interpretation of multiparametric magnetic resonance imaging (mpMRI). Materials and Methods: Twelve mpMRIs were shown to 73 urologists from seven Italian institutions. Responders were asked to identify the site of the suspicious nodule (SN) but not to assign a PIRADS score. We set an a priori cut-off of 75% correct identification of SN as a threshold for proficiency in mpMRI reading. Data were analyzed according to urologists’ hierarchy (UH; resident vs. consultant) and previous experience in fusion prostate biopsies (E-fPB, defined as <125 vs. ≥125). Additionally, we tested for differences between non-proficient vs. proficient mpMRI readers. Multivariable logistic regression analyses (MVLRA) tested potential predictors of proficiency in mpMRI reading. Results: The median (IQR) number of correct identifications was 8 (6–8). Anterior nodules (number 3, 4 and 6) represented the most likely prone to misinterpretation. Overall, 34 (47%) participants achieved the 75% cut-off. When comparing consultants vs. residents, we found no differences in terms of E-fPB (p = 0.9) or in correct identification rates (p = 0.6). We recorded higher identification rates in urologists with E-fBP vs. their no E-fBP counterparts (75% vs. 67%, p = 0.004). At MVLRA, only E- fPB reached the status of independent predictor of proficiency in mpMRI reading (OR: 3.4, 95% CI 1.2–9.9, p = 0.02) after adjusting for UH and type of institution. Conclusions: Despite urologists becoming more familiar with interpretation of mpMRI, their results are still far from proficient. E-fPB enhances the proficiency in mpMRI interpretation.

Verified
Journal Article
Open access
PDF file
ACAntonella Centemero
Antonella Centemero
LRLorenzo Rigatti
Lorenzo Rigatti
DGDonatella Giraudo
Donatella Giraudo
Guglielmo ManticaGuglielmo Mantica
Guglielmo Mantica
DMDavide De Marchi
Davide De Marchi
FGFranco Gaboardi
Franco Gaboardi
Introduction: The aim of the study is to evaluate the effectiveness of a Multi-disciplinary team (MDT) and multi-disciplinary approach in the treatment of Chronic Pelvic Pain (CPP). Methods: The data of all consecutive patients referred for a CPP from 11/2016 to 2/2019 has been prospectively collected. The sample was divided in two groups: Group A, made by patients managed after the institution of our MDT, and Group B, made of patients managed before this date. The MDT is composed by three urogynecologists, a psychologist and a physiotherapist. All Group A patients underwent a weekly bladder instillation with dimethyl sulfoxide (DMSO), kinesiotherapy for trigger points and Percutaneous Tibial Nerve Stimulation for 10 consecutive weeks. Patients were asked to perform a self-treatment following the Stanford Protocol and to adhere to a specific diet. All Group B patients were managed only with DMSO instillations and a strict diet. Results: The Group A was made of 41 females and 6 males while the Group B was made of 38 females and 5 males. The Group A patients showed a statistically significant improvement in the Pelvic Pain Urgency Frequency, in the frequency times reported at the 6 months voiding diary, and a better Patient Global Impression of Improvement. Conclusions: Our data support the efficacy of the MDT in the management of CPP. The multimodal approach might represent an effective and reproducible non-invasive option to manage successfully CPP.

7 January 2022 in Medicina
Verified
Journal Article
Open access
PDF file
Guglielmo ManticaGuglielmo Mantica
Guglielmo Mantica
Francesco ChierigoFrancesco Chierigo
Francesco Chierigo
RMRafaela Malinaric
Rafaela Malinaric
SSSalvatore Smelzo
Salvatore Smelzo
FAFrancesca Ambrosini
Francesca Ambrosini
CTCarlo Terrone
Carlo Terrone
Background and Objectives: To evaluate the oncological impact of squamous cell carcinoma (SCC) variant in patients submitted to intravesical therapy for non-muscle-invasive bladder cancer (NMIBC). Materials and Methods: Between January 2015 and January 2020, patients with conventional urothelial NMIBC (TCC) or urothelial NMIBC with SCC variant (TCC + SCC) and submitted to adjuvant intravesical therapies were collected. Kaplan–Meier analyses targeted disease recurrence and progression. Uni- and multivariable Cox regression analyses were used to test the role of SCC on disease recurrence and/or progression. Results: A total of 32 patients out of 353 had SCC at diagnosis. Recurrence was observed in 42% of TCC and 44% of TCC + SCC patients (p = 0.88), while progression was observed in 12% of both TCC and TCC + SCC patients (p = 0.78). At multivariable Cox regression analyses, the presence of SCC variant was not associated with higher rates of neither recurrence (p = 0.663) nor progression (p = 0.582). Conclusions: We presented data from the largest series on patients with TCC and concomitant SCC histological variant managed with intravesical therapy (BCG or MMC). No significant differences were found in term of recurrence and progression between TCC and TCC + SCC. Despite the limited sample size, this study paves the way for a possible implementation of the use of intravesical BCG and MMC in NMIBC with histological variants.